test

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca Shares fell on Disappointing Q2 Results and Cancer Study Results

AstraZeneca plc (NYSE: AZN) released a bevy of news today, including Q2 results, as well as study results for two drugs. AZN price has plummeted 15%.Following the loss of exclusivity for Crestor and Seroquel XR AstraZeneca had expected losses in the..

U.S. Arts and Craft Store, Michaels’ earnings fell below estimates

U.S. Arts and Craft Store, Michaels’ earnings fell below estimates

Michaels Companies, Inc. (NASDAQ: MIK) fell short early trading day on Tuesday, as earnings reported less than analyst estimates. According to their press release, Michaels reported a net sales of $1.16M, a decrease of 1.2% from Q1 2016. Operat..

Hasbro Reported better-than-expected Revenue

Hasbro Reported better-than-expected Revenue

Hasbro, Inc. (NASDAQ: HAS) on Monday report first quarter earnings that beat analysts’ estimates, helped by robust revenue from its entertainment and licensing business.The company said revenue rose 2.2 percent to $849.7 million in the quarter..